Related Experiment Videos

[Neonatal Morbidity and Gestational Diabetes: Coincidence or Consequence of the 2011 Protocol]

Gabriela Mimoso1, Guiomar Oliveira2

  • 1Serviço de Neonatologia. Maternidade Bissaya Barreto. Centro Hospitalar e Universitário de Coimbra. Coimbra. Portugal.

Acta Medica Portuguesa
|October 14, 2017
PubMed

Insights

Early diagnosis of gestational diabetes (GDM) and strict metabolic control increased neonatal complications, including hypoglycemia and congenital anomalies. Further national data analysis is needed to understand this trend.

Area of Science:

  • Obstetrics and Gynecology
  • Neonatology
  • Endocrinology

Background:

  • Gestational diabetes (GDM) is a pregnancy complication linked to increased perinatal risks.
  • Effective metabolic control in GDM is crucial for reducing adverse outcomes.
  • Recent diagnostic criteria allow for earlier GDM detection, even in the first trimester.

Purpose of the Study:

  • To compare neonatal morbidity in pregnancies with GDM diagnosed before and after the 2011 Portuguese guidelines.
  • To evaluate the impact of updated diagnostic criteria on perinatal outcomes.

Main Methods:

  • Retrospective analysis of 774 unifetal pregnancies complicated by GDM.
  • Data collected from a perinatal database between 2008 and 2013.
  • Comparison of neonatal morbidity across two three-year periods defined by guideline implementation.

Main Results:

  • Gestational diabetes was diagnosed earlier post-guideline implementation.
  • Increased frequency of insulin therapy was observed.
  • Neonatal morbidity rose, with more cases of hypoglycemia, congenital anomalies, and smaller-than-expected newborns.

Conclusions:

  • The observed increase in neonatal morbidity is associated with earlier GDM diagnosis and intensified metabolic management.
  • Further investigation using national data is essential to fully comprehend these unexpected morbidity trends.
Abstract

Related Concept Videos